Cureus 16 , e61783
Patients taking insulin or sulfonylureas with tirzepatide should be particularly vigilant for signs of hypoglycemia (shakiness, sweating, confusion, dizziness) and contact their provider if these occur, as medication adjustments may be needed
Nutr Metab (Lond) 13, 92 (2016)
This led to higher levels of cyclin D1, a protein crucial for promoting cell proliferation, suggesting a potential pathway for GLP-1RAs to increase risk for PDAC in humans
Chen Z, Liu C, Patel AJ, Liao CP, Wang Y, Le LQ
Timeline for Results We know patience is hard when you're trying to conceive, so understanding the biology can help set realistic expectations: Metabolic markers (fasting insulin, HOMA-IR): Improvements may appear within 6-12 weeks of consistent supplementation